Showing results (251-260 of 261) with videos related to
Sort By:
Pageof 27
Cancer Control : Journal of the Moffitt Cancer Center|January 4, 2023
Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART)J M Bryant, Russell F Palm, Roberto Herrera, et al.The Journal of Biological Chemistry|July 24, 2010
A combined zinc/cadmium sensor and zinc/cadmium export regulator in a heavy metal pumpLone Baekgaard, Maria D Mikkelsen, Danny M Sørensen, et al.Journal of Electrocardiology|July 24, 2026
Reliability of resting heart rate measurements in atrial fibrillationAnders P Persson, William F McIntyre, Taya Glotzer, et al.The Journal of Experimental Medicine|October 6, 1999
Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responsesA J Coyle, C Lloyd, J Tian, et al.Nature Communications|January 29, 2025
Intricacies of human-AI interaction in dynamic decision-making for precision oncologyDipesh Niraula, Kyle C Cuneo, Ivo D Dinov, et al.Medrxiv : the Preprint Server for Health Sciences|May 15, 2024
Intricacies of Human-AI Interaction in Dynamic Decision-Making for Precision Oncology: A Case Study in Response-Adaptive RadiotherapyDipesh Niraula, Kyle C Cuneo, Ivo D Dinov, et al.Der Nervenarzt|May 28, 2021
[Telemedicine in stroke-pertinent to stroke care in Germany]J Barlinn, S Winzer, H Worthmann, et al.Annals of Surgical Oncology|April 5, 2023
FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic ReviewDilmurodjon Eshmuminov, Botirjon Aminjonov, Russell F Palm, et al.European Journal of Neurology|July 11, 2013
Etiology of first-ever ischaemic stroke in European young adults: the 15 cities young stroke studyN Yesilot Barlas, J Putaala, U Waje-Andreassen, et al.Journal of the National Cancer Institute|July 13, 2026
Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: a multinational analysisVictor Lopez-Lopez, Tanja Hasse, Philipp Houben, et al.Pageof 27